French drugmaker Sanofi's sales and profit fell in the second quarter despite double-digit growth at biotech arm Genzyme, as the diabetes division continued to come under sustained US pricing pressure.
Business net income fell
UAE’s Ministry of Health and Prevention has partnered with healthcare provider Sanofi for an initiative to improve physicians and nurses’ capabilities in providing standardised treatment for diabetes patients.
The World Health Organization's expert group on immunisation said it recommended that countries consider introducing Sanofi's dengue vaccine Dengvaxia in areas where prevalence of the virus was 50 per cent or higher.
Sanofi, a global healthcare leader, has appointed Jean-Paul Scheuer as its country chair and general manager, Rx, for Gulf countries, effective March 10.
He succeeds Ayman Mokhtar, the company’s former country chair and gene
The UAE's Ministry of Health and Sanofi are in a key long-term partnership programme to enhance the pharmacovigilance infrastructure through developing pharmacists' skills, efficiency and performance in alignment with the unified healt
The World Organisation of Family Medicine (Wonca) East Mediterranean Region and Sanofi, a global healthcare leader, have signed a two-year agreement to deliver a series of educational training sessions to family physicians in the UAE.
Sanofi, a global and diversified healthcare leader, has announced the start of the first phase of local generic medicines production through Dubai-based Globalpharma at a special ceremony today (October 28).
The announcement follo
French drugmaker Sanofi, developing the first vaccine against dengue fever, said its product reduced disease cases by 60.8 per cent in a large final clinical trial.
Sanofi has invested more than 1.3 billion euros ($1.7 billion) in
Private equity firms are mulling over a $10 billion plan to buy and merge older drug brands of Britain's GlaxoSmithKline and France's Sanofi, the Financial Times reported on Sunday, citing sources.
U.S.-based KKR and Warbu